View Profile

Zoran Todorovic

Department of Pharmacology, Clinical Pharmacology and Toxicology · University of Belgrade Faculty of Medicine

https://researchid.co/zoran.todorovic
@studiesinenglish.med.bg.ac.rs
108Scopus Publications

Research Interests

Clinical Pharmacology, Laboratory Animal Science, Pharmaceutical Medicine, Bioethics

Biography

Full Professor of Pharmacology, Clinical Pharmacology, and Toxicology (since 2008). Postdoc at the William Harvey Research Institute, London, UK (1999-2001). Visiting Scientist at the Dept. of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden (2016). Visiting Professor, Icahn School of Medicine at Mount Sinai, NYC (2017). Clinical Pharmacology Residency Program Chairman, UBFM (since 2021). Former Chairmen of Pharmacology, UBFM. Clinical pharmacologist at the 3rd level hospital (since 2011). Clinical trial experience: > 10 phase III/IV studies (role: clinical pharmacologist). More than 300 publications (> 70 CC/SCI in extenso publications) and more than 700 citations in CC/SCI journals. Council of Europe Expert in professional ethics and higher education reform, and member of the Serbian Royal Medical Board.

Education

MD Faculty of Medicine, University of Belgrade, 1989 MSc in Medicine (Pharmacology) Faculty of Medicine, University of Belgrade, 1993 PhD in Medicine (Pharmacology) Faculty of Medicine, University of Belgrade, 1996 Clinical Pharmacology (specialization) Faculty of Medicine, University of Belgrade, 1996 Clinical Pharmacology - Pharmacotherapy (sub-specialization) Faculty of Medicine, University of Belgrade, 2008

Recent Scopus Publications

  1. The alarming rate of carbapenem-resistant Klebsiella pneumoniae in Serbia: A deep dive into genomic diversity, resistome, hypervirulence, and expansion of high-risk clone ST147/blaNDM-1
    Microbiological Research, 2026
  2. Antibiotic Usage and Healthcare-Associated Clostridioides difficile in Patients with and Without COVID-19: A Tertiary Hospital Experience
    Antibiotics, 2025
  3. Lipidomics, Microbiota, and Intestinal Clostridioides difficile Infection Outcome
    International Journal of Molecular Sciences, 2025
  4. Vaccine Hesitancy in Public Healthcare During Pandemics: An International Study to Inform Management Learning
    Health Science Reports, 2025
  5. Potential New Drug Targets Modulating the Environmentally-Induced Oxidative Stress in the Cardiovascular System
    Advances in Biochemistry in Health and Disease, 2024

Links